ACR 2018 - Day 3 Report
Highlights from Tuesday, day 3 of the ACR Annual meeting in Chicago, included:
The PEXIVAS Study – 2x2 Trial of Plasma Exchange and Reduced Steroids in ANCA-Associated Vasculitis (AAV) - Abstract #2788
News
Axial Spondylitis Abstracts Roundup
There have been a number of interesting posters and presentations covering the field of axial spondyloarthropathy. I’ve picked out a few points that I found particularly relevant.
Classification Criteria
Negotiation Skills for Rheumatologists
Physicians as a group are trained to have excellent clinical skills, but the difference between an average and extremely successful physician often comes down to factors outside of their ability to provide clinical care.
NK cells and a Potential Role in the Development of PsA vs PsC (Cutaneous Psoriasis)
Human NK cells express multiple receptors that interact with HLA class I molecules which, in turn, suppy peptides that bind HLA-E to form CD94/NKG2A NK receptor ligands.
What is the Future of MTX for Psoriatic Arthritis?
Like most rheumatologists, I retain a deep and abiding love for methotrexate.
Autoimmunity in the Setting of Primary Immunodeficiency
There are many avenues for interdisciplinary collaboration within rheumatology, as our specialty encompasses every organ system and diseases with protean manifestations.
ACR 2018 Podcast - Day 2B
Audio Highlights and Interviews from Day 2 at the ACR 2018 meeting - LISTE
ACR 2018 - Day 2 Report
Monday was a packed day of sessions and studies. Here are our just a few of our highlights.
ACR 2018 Podcast - Day 1B
Audio Highlights and Interviews from Day 1 at the ACR 2018 meeting - LISTEN HERE
ACR 2018 Podcast - Day 2A
Audio Highlights and Interviews from Day 2 at the ACR 2018 meeting - LISTEN HERE
Technology Tools for the Rheumatologist
Four years ago, the genesis of this session (technology tools for rheumatologists) was from the frustration of the archaic technologies we have been using in our medical practices (including user hostile EHRs), compared to the rapid advancing pace of the consumer technologies we use at home. So came the struggle to adapt affordable and usable consumer technology products in the office that would save time (or at least be time neutral) and impact patient management.
Is DAS28 and HAQ-DI Headed for the Graveyard?
Dr. Joseph Smolen delivered one of the most elegant and informative talk on rheumatoid arthritis at this ACR’s meeting as a tribute to Dr. Paul Klemperer. Dr. Smolen led us on a journey, and had us feeling content with what we are doing in practice as we walked with him from historical discoveries of RA through new drug development. Then Dr. Smolen did the unthinkable: he made us crash!
ACR 2018 Podcast - Day 1A
Check out the first part of our Day 1 Podcast from ACR 2018 - LISTEN HERE
Several Studies Addressed Treatment of Axial Spondylitis
Monday afternoon's session on the treatment of Axial Spondyloarthritis presented us with a great selection of studies addressing important issues in modern treatment paradigm of AxSpA.
TRIPLE Trial Results
Pegloticase has become an excellent option for management of patients with chronic refractory gout, although treatment may be limited by the development of anti-drug antibodies that lead to loss of serum urate (sUA) lowering effect.
